FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

385101003: Ointment (basic dose form)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479363017 Ointment en Synonym Active Entire term case insensitive SNOMED CT core module
3534592017 Ointment (basic dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ointment Is a Type of drug preparation false Inferred relationship Existential restriction modifier
Ointment Is a Basic dose form with semi-solid state of matter true Inferred relationship Existential restriction modifier
Ointment Has state of matter Semi-solid true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Neo-Cortef ear/eye ointment (Pliva Pharma Ltd) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1.5% / Neomycin 0.5% ear/eye ointment 3.9 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Neo-Cortef ear/eye ointment (Pliva Pharma Ltd) 3.9 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment (A A H Pharmaceuticals Ltd) 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment (Martindale Pharmaceuticals Ltd) 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment (Unichem Plc) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment (Unichem Plc) 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment (A A H Pharmaceuticals Ltd) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment (Martindale Pharmaceuticals Ltd) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 55 ml Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 25 ml Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Germoloids ointment (Bayer Plc) 25 ml Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Germoloids ointment (Bayer Plc) 55 ml Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Germoloids ointment (Bayer Plc) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Germoloids ointment (Bayer Plc) 15 ml Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 15 ml Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Simple ointment (A A H Pharmaceuticals Ltd) 500 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Simple ointment (A A H Pharmaceuticals Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Simple ointment 500 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Simple ointment Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Arnica / Urtica urens ointment Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Arnica / Urtica urens ointment 25 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Combudoron ointment (Weleda (UK) Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Combudoron ointment (Weleda (UK) Ltd) 25 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Chamomile extract 10.5% ointment 50 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Kamillosan 10.5% ointment (Goldshield Healthcare Ltd) 50 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Kamillosan 10.5% ointment (Goldshield Healthcare Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Chamomile extracts 10.5% ointment Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Glyceryl trinitrate 0.2% ointment (Special Order) 1 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Glyceryl trinitrate 0.2% ointment 1 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 2 milligram/1 gram conventional release rectal ointment Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Glyceryl trinitrate 0.2% ointment (Special Order) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Sodium chloride 5% eye ointment 1 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Sodium chloride 5% eye ointment (Part VIIID Drug Tariff Special Order) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Sodium chloride 5% eye ointment (Part VIIID Drug Tariff Special Order) 1 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely sodium chloride 50 milligram/1 gram conventional release eye ointment Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Oftalmolosa Cusi Eritromicina 0.5% eye ointment (Alcon Cusi S.A.) 3.5 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Erythromycin 0.5% Ophthalmic Ointment (E. Fougera & Co) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Erythromycin 0.5% Ophthalmic Ointment (E. Fougera & Co) 3.5 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Oftalmolosa Cusi Eritromicina 0.5% eye ointment (Alcon Cusi S.A.) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Erythromycin 0.5% eye ointment Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Erythromycin 0.5% eye ointment 3.5 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Hydromol ointment (Ferndale Pharmaceuticals Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Hydromol ointment (Ferndale Pharmaceuticals Ltd) 500 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Epaderm emulsifying ointment (Medlock Medical) 500 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Epaderm ointment (Molnlycke Health Care Ltd) 1000 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Emulsifying wax 30% / Yellow soft paraffin 30% ointment 1000 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Emulsifying wax 30% / Yellow soft paraffin 30% ointment Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Epaderm emulsifying ointment (Medlock Medical) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Emulsifying wax 30% / Yellow soft paraffin 30% ointment 500 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Hydromol ointment (Ferndale Pharmaceuticals Ltd) 125 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Epaderm emulsifying ointment (Medlock Medical) 125 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Emulsifying wax 30% / Yellow soft paraffin 30% ointment 125 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous ointment Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Dermovate 0.05% ointment (GlaxoSmithKline) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Dermovate 0.05% ointment (GlaxoSmithKline) 100 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Dermovate 0.05% ointment (GlaxoSmithKline) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Clobetasol 0.05% ointment 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Clobetasol 0.05% ointment 100 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Mometasone 0.1% ointment (PI) (Dowelhurst Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (PI) (Dowelhurst Ltd) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (PI) (Waymade Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (PI) (Dowelhurst Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (Organon Pharma (UK) Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (Doncaster Pharmaceuticals Ltd) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (Organon Pharma (UK) Ltd) 100 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (Sigma Pharmaceuticals Plc) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (PI) (Waymade Ltd) 100 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Mometasone 0.1% ointment 100 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous ointment Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (Sigma Pharmaceuticals Plc) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Mometasone 0.1% ointment 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Mometasone 0.1% ointment (PI) (Dowelhurst Ltd) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (Organon Pharma (UK) Ltd) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Elocon 0.1% ointment (PI) (Waymade Ltd) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Generic Ultraproct ointment Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Generic Ultraproct ointment 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Ultraproct ointment (Meadow Laboratories) 30 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Ultraproct ointment (Meadow Laboratories) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Modrasone 0.05% ointment (Pliva Pharma Ltd) Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Modrasone 0.05% ointment (Pliva Pharma Ltd) 50 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Alclometasone 0.05% ointment 50 gram Has dispensed dose form True Ointment Inferred relationship Existential restriction modifier
Mupirocin 2% nasal ointment (PI) (Dowelhurst Ltd) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Mupirocin 2% nasal ointment (PI) (Dowelhurst Ltd) 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Doncaster Pharmaceuticals Ltd) 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Sigma Pharmaceuticals Plc) 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (GlaxoSmithKline) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (GlaxoSmithKline) 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Doncaster Pharmaceuticals Ltd) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (PI) (Dowelhurst Ltd) 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release nasal ointment Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (PI) (Dowelhurst Ltd) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (PI) (Waymade Ltd) 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Mupirocin 2% nasal ointment 3 gram Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Sigma Pharmaceuticals Plc) Has dispensed dose form False Ointment Inferred relationship Existential restriction modifier

Start Previous Page 23 of 64 Next End


This concept is not in any reference sets

Back to Start